Literature DB >> 34767863

Tumor associated macrophage and microbe: The potential targets of tumor vaccine delivery.

Jipeng Jiang1, Jie Mei2, Shaoqiong Yi3, Changjiang Feng3, Yongfu Ma3, Yang Liu4, Ying Liu5, Chunying Chen6.   

Abstract

The occurrence and development of tumors depend on the tumor microenvironment (TME), which is made of various immune cells, activated fibroblasts, basement membrane, capillaries, and extracellular matrix. Tumor associated macrophages (TAMs) and microbes are important components in TME. Tumor cells can recruit and educate TAMs and microbes, and the hijacked TAMs and microbes can promote the progression of tumor reciprocally. Tumor vaccine delivery remodeling TME by targeting TAM and microbes can not only enhance the specificity and immunogenicity of antigens, but also contribute to the regulation of TME. Tumor vaccine design benefits from nanotechnology which is a suitable platform for antigen and adjuvant delivery to catalyze new candidate vaccines applying to clinical therapy at unparalleled speed. In view of the characteristics and mechanisms of TME development, vaccine delivery targeting and breaking the malignant interactions among tumor cells, TAMs, and microbes may serve as a novel strategy for tumor therapy.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Macrophage; Microbiota; Tumor microenvironment; Tumor vaccine; Vaccine delivery

Mesh:

Substances:

Year:  2021        PMID: 34767863     DOI: 10.1016/j.addr.2021.114046

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  4 in total

Review 1.  Recent Advances and Challenges in Cancer Immunotherapy.

Authors:  Chelsea Peterson; Nathan Denlinger; Yiping Yang
Journal:  Cancers (Basel)       Date:  2022-08-17       Impact factor: 6.575

2.  Integrated Analysis of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma.

Authors:  Yulan Zhao; Ting Huang; Pintong Huang
Journal:  Diagnostics (Basel)       Date:  2022-08-08

Review 3.  Cancer cell membrane-wrapped nanoparticles for cancer immunotherapy: A review of current developments.

Authors:  Qi Jiang; Mixue Xie; Ruyin Chen; Feifei Yan; Chanqi Ye; Qiong Li; Shuaishuai Xu; Wei Wu; Yunlu Jia; Peng Shen; Jian Ruan
Journal:  Front Immunol       Date:  2022-08-29       Impact factor: 8.786

Review 4.  Microbiome in cancer: An exploration of carcinogenesis, immune responses and immunotherapy.

Authors:  Pei Zhou; Yawen Hu; Xiaoyan Wang; Luxuan Shen; Xinghao Liao; Yajuan Zhu; Jiadong Yu; Fulei Zhao; Yi Zhou; Hengshui Shen; Jiong Li
Journal:  Front Immunol       Date:  2022-08-08       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.